Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLAND PHARMA Plunges 4%; BSE HEALTHCARE Index Up 1.1%
Wed, 7 Aug 10:14

GLAND PHARMA Plunges 4%; BSE HEALTHCARE Index Up 1.1%Image source: ThinkNeo/www.istockphoto.com

GLAND PHARMA share price has plunged 4% and is presently trading at Rs 2,033.5.

Meanwhile, the BSE HEALTHCARE index is at 40,469.5 (up 1.1%).

Among the top losers in the BSE HEALTHCARE index today are Jubilant Pharmova (down 0.9%) and FORTIS HEALTHCARE (down 0.5%).

AJANTA PHARMA (up 5.7%) and Natco Pharma (up 4.1%) are among the top gainers today.

Over the last one year, GLAND PHARMA has moved up from Rs 1,343.9 to Rs 2,033.5, registering a gain of Rs 689.7 (up 51.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 40,469.5, registering a gain of 43.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 114.3%), GRANULES INDIA (up 105.4%) and GSK Pharma (up 103.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,162.4 (up 0.7%).

The top gainers among the BSE Sensex today are MUNDRA PORT & SEZ (up 2.2%) and Maruti Suzuki (up 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,198.8 (up 0.9%). ONGC and Coal India are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,162.4, registering a gain of 13,208.9 points (up 20.0%).

GLAND PHARMA Financial Update...

GLAND PHARMA net profit fell 25.9% YoY to Rs 1,438 million for the quarter ended June 2024, compared to a profit of Rs 1,941 million a year ago. Net sales rose 16.0% to Rs 14,017 million during the period as against Rs 12,087 million in April-June 2023.

For the year ended March 2023, GLAND PHARMA reported 35.5% decrease in net profit to Rs 7,810 million compared to net profit of Rs 12,117 million during FY22. Revenue of the company fell 17.6% to Rs 36,246 million during FY23.

The current Price to earnings ratio of GLAND PHARMA, based on rolling 12 month earnings, stands at 46.4.


Equitymaster requests your view! Post a comment on "GLAND PHARMA Plunges 4%; BSE HEALTHCARE Index Up 1.1%". Click here!